Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Laryngo- Rhino- Otologie|February 12, 2024
[Systemic therapies for advanced thyroid cancer - an update]Tim Brandenburg, Yara Maria Machlah, Dagmar Führer-SakelDeutsche Medizinische Wochenschrift (1946)|November 2, 2023
[Systemic therapies for advanced thyroid cancer - an update]Tim Brandenburg, Yara Maria Machlah, Dagmar Führer-SakelInnere Medizin (Heidelberg, Germany)|January 17, 2024
[Precision medicine in endocrinology exemplified by medullary thyroid cancer]Tim Brandenburg, Yara Maria Machlah, Dagmar FührerThe Journal of Clinical Endocrinology and Metabolism|March 17, 2023
The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative MedicineAndreas Machens, Kerstin Lorenz, Tim Brandenburg, et al.Endocrine-Related Cancer|May 16, 2024
Genotype-specific development of MEN 2 constituent components in 683 RET carriersAndreas Machens, Kerstin Lorenz, Frank Weber, et al.Endocrine|July 21, 2023
Clinical presentation of MEN 2A in index vs. non-index patientsAndreas Machens, Kerstin Lorenz, Frank Weber, et al.Medizinische Klinik (Munich, Germany : 1983)|June 18, 2009
[Thyroid diseases and pregnancy]Stefan Karger, Dagmar Führer-SakelPathology, Research and Practice|September 26, 2025
A subgroup of anaplastic thyroid carcinomas harbors MET alterations with potential therapeutic optionsSarah Theurer, Hans-Ulrich Schildhaus, Thomas Herold, et al.Surgery|October 11, 2023
Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomyHenning Dralle, Tim Brandenburg, Frank Weber, et al.European Journal of Endocrinology|December 23, 2025
Real-world efficacy and safety of selpercatinib in RET-mutant medullary thyroid cancer at a Tertiary Referral CenterYara Maria Machlah, Lynn Marlene Srasra, Sarah Theurer, et al.Pageof 8